Norketotifen for the Treatment of Uncomplicated Influenza-like Illness

PHASE2CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

October 21, 2019

Primary Completion Date

April 5, 2020

Study Completion Date

April 20, 2020

Conditions
Influenza -Like Illness
Interventions
DRUG

Norketotifen

Oral capsule

DRUG

Placebo

Oral capsule

Trial Locations (18)

28277

OnSite Clinical Solutions, Charlotte

33135

South Florida Research Center, Miami

33165

Premier Research Associate, Miami

33607

Gulfcoast Medical Research, Tampa

35235

Cahaba Research, Birmingham

57702

Health Concepts, Rapid City

63141

The Clinical Research Center, St Louis

70124

DelRicht Research, New Orleans

70809

DelRicht Research, Baton Rouge

75010

Family Medicine Associates of Texas, Carrollton

75024

Village Health Partners, Plano

75204

CityDoc Urgent Care, Dallas

78735

Premier Family Physicians, Austin

80246

AFC Urgent Care, Denver

85032

Precision Trials AZ, Phoenix

90806

Long Beach Clinical Trial Services, Long Beach

91767

Empire Clinical Research, Pomona

95821

Northern California Research, Sacramento

Sponsors
All Listed Sponsors
lead

Emergo Therapeutics, Inc.

INDUSTRY